Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dolomite Expertise Brings Microfluidic Product to Market

Published: Monday, June 24, 2013
Last Updated: Monday, June 24, 2013
Bookmark and Share
Fledgling spin-out company Drop-Tech has turned to microfluidics specialist Dolomite for its product development and fabrication skills.

Dolomite to help productize the advanced and innovative Robo¬Drop™ technology into the Mitos Dropix, a droplet-on-demand sampler that is set to make it easy to produce extremely miniaturized droplet compartments with excellent control over their contents.

Access to this new high-throughput screening format will prove invaluable in basic research, drug discovery and diagnostics applications.

The collaboration began when Drop-Tech entered – and won – Dolomite’s Productizing Science® Competition, sparking discussions and exchanges of ideas between the two development teams. Liisa van Vliet, a Post-doctoral Research Associate at the University of Cambridge and Managing Director of Drop-Tech, explained: “Drop-Tech was formed from an academic collaboration between Imperial College London and the University of Cambridge. In a university environment, finding the time to convert an invention into a product is often difficult, so we welcomed Dolomite’s offer to accelerate product development, fast-tracking the transition from idea to market; Dolomite knows and understands microfluidic droplet technologies and has the engineering expertise to productize the instrument. Drop¬Tech’s Technical Director Fabrice Gielen and I met with Dolomite’s product development team to discuss the internal workings of the instrument. Together, we were able to bounce ideas back and forth to incorporate improvements and determine a list of specifications.”

The Mitos Dropix sampler allows the creation of nanoliter droplet sequences from up to 24 different samples, with precise control over droplet content and size, as well as the spacing between droplets. It can be used as an add-on for conventional microfluidic chips, delivering droplets for merging, further miniaturization, dilution or any other droplet manipulation, and will also be an invaluable tool to use in conjunction with other analytical and liquid handling systems. The first batch of instruments will be with beta testers by summer 2013, and further collaboration is planned to develop droplet analysis capabilities on upcoming versions of the instrument.

Liisa concluded: “This has been a great start to our collaboration. From the beginning, our aim was to make microfluidics easier and, with Dolomite’s help, we will be able to provide scientists with an easy-to-use instrument that can dispense controlled, user-defined sequences of nanoliter droplets for a range of diverse applications.” Drop-Tech and Dolomite are already looking forward to additional Productizing Science collaborations in the future.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Ribosome Recycling as a Drug Target
Researchers explain mechanism that recycles bacterial ribosomes stalled on messenger RNAs that lack termination codons.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!